Cover Image

Scaffold Versus Repeat Drug‐Coated Balloon Therapy for Early and Late Drug‐Coated Balloon Restenosis in Femoropopliteal Arteries: Results of the RECURRENCE‐2 Study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Takashi Yanagiuchi, Takahiro Tokuda, Akiko Tanaka, Shunsuke Kojima, Kohei Yamaguchi, Tatsuro Takei, Naoki Yoshioka, Kenji Ogata, Tatsuya Nakama, Hirokazu Yokoi
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Catheterization and Cardiovascular Interventions
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

One‐Year Outcomes of Drug‐Coated Balloon Angioplasty With and Without the Blades‐Up Function of the JETSTREAM Atherectomy Device in Femoropopliteal Calcified Lesions
by: Tatsuro Takei, et al.
Published: (2026)

The Clinical Outcome of Drug‐Coated Balloon Following Jetstream and Drug‐Coated Balloon for Femoropopliteal Nodular Calcification Lesions: The Results of the Multicenter ORION Study
by: Kenji Ogata, et al.
Published: (2026)

Comparing the Clinical Performance of High‐Dose and Low‐Dose Drug‐Coated Balloons for Long Femoropopliteal Artery Disease: Results of the SATELLITE Study
by: Naoki Yoshioka, et al.
Published: (2025)

Comparing the Clinical Performance of Paclitaxel‐Coated Balloons and Paclitaxel‐Eluting Stent for Treating Long Femoropopliteal Artery Disease: Results of the CAPELLA Study
by: Naoki Yoshioka, et al.
Published: (2025)

Comparative Outcomes of Supera Interwoven Nitinol Versus Eluvia Fluoropolymer‐Based Drug‐Eluting Stents for the Treatment of Severely Calcified Femoropopliteal Artery Lesions: Results of the ELDORADO Study
by: Takashi Yanagiuchi, et al.
Published: (2025)

Impact of Below‐the‐Knee Runoff in Patients With Lower Extremity Artery Disease Who Underwent Endovascular Therapy Using Drug‐Coated Balloons in Femoropopliteal Lesions
by: Takehiro Yamada, et al.
Published: (2024)

Three Year Clinical Outcomes of Drug‐Coated Balloons in Patients With Femoropopliteal Chronic Total Occlusion: Results From the Multicenter EAGLE Study
by: Naoki Hayakawa, et al.
Published: (2025)

Long‐Term Clinical Impact of Successful Vessel Preparation in Femoropopliteal Drug‐Coated Balloon Angioplasty
by: Yusuke Tomoi, et al.
Published: (2025)

Impact of Intra‐Calcium Wiring Followed by Rotational Atherectomy and Subsequent Drug‐Coated Balloon Treatment for Femoropopliteal Artery Calcified Lesions
by: Yasunari Sakamoto, et al.
Published: (2025)

Enhanced Drug Effect With Cutting Balloon Followed by Drug Coated Balloon in a Rabbit Model
by: Manabu Shiozaki, et al.
Published: (2025)

Paclitaxel‐Coated Balloons for Femoropopliteal Artery Disease Treatment in French Patients: A Longitudinal Observational Study
by: Yann Gouëffic, et al.
Published: (2025)

Cardiovascular Outcomes of Drug‐Coated Balloon Versus Drug‐Eluting Stents for Femoropopliteal Peripheral Arterial Disease Interventions: A Meta‐Regression Analysis
by: Yasar Sattar, et al.
Published: (2026)

Distal Embolization of Calcified Nodules and Cholesterol Crystals After JETSTREAM Atherectomy for Femoropopliteal Lesion, Identified by Pathology and MicroCT
by: Shunsuke Kojima, et al.
Published: (2025)

The Predictive Value of Quantitative Flow Ratio and Its Derived Angiographic Microvascular Resistance for Restenosis Following Drug‐Coated Balloon Angioplasty
by: Chenhang Wang, et al.
Published: (2025)

Drug‐Coated Balloons in Coronary Artery Disease: Engineering, Pharmacology, and the Mechanisms Behind Angiographic Outcomes
by: Marcello Marchetta, et al.
Published: (2026)

Drug‐Coated Balloon‐Based Versus Drug‐Eluting Stent‐Only Treatment for Large Vessel Coronary Artery Disease
by: Eun‐Seok Shin, et al.
Published: (2025)

Drug‐Coated Balloons Versus Non‐Coated Balloons for Side Branch Treatment in Bifurcation Lesions: A Systematic Review and Meta‐Analysis
by: Matteo Rocchetti, et al.
Published: (2025)

Drug‐Coated Balloon‐Based Treatment of Left Main True Bifurcation Lesion
by: Ae‐Young Her, et al.
Published: (2025)

Paclitaxel‐Coated Balloon for the Management of In‐Stent Coronary Restenosis: An Updated Meta‐Analysis and Trial Sequential Analysis
by: Vinícius M. R. Oliveira, et al.
Published: (2025)

Three‐Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions
by: Taka‐aki Takamura, et al.
Published: (2025)

Drug‐Coated Balloons Versus Drug‐Eluting Stents in Small Vessel De Novo Coronary Artery Disease: A Systematic Review and Meta‐Analysis
by: Fahad Raja Khan, et al.
Published: (2025)

Long‐Term Efficacy and Safety of Sirolimus‐Coated Balloon in Femoropopliteal Steno‐Occlusive Disease: 3‐Year Outcomes
by: Michele Franzese, et al.
Published: (2025)

Application of Drug‐Coated Balloons in Complex High Risk and Indicated Percutaneous Coronary Interventions
by: Yvemarie B. O. Somsen, et al.
Published: (2024)

Drug‐Coated Balloon‐Based Versus Drug‐Eluting Stent‐Only Treatment for Patients With High‐Bleeding Risk
by: Eun‐Seok Shin, et al.
Published: (2026)

A Comparison of a Drug Coated Balloon With Drug Eluting Stent Strategy for Treating Coronary Bifurcation Lesions
by: Natasha Corballis, et al.
Published: (2025)

Critique on “Paclitaxel‐Coated Balloon for the Management of In‐Stent Coronary Restenosis: An Updated Meta‐Analysis and Trial Sequential Analysis”
by: Emaan Sadiq
Published: (2025)

Critique on “Drug‐Coated Balloons Versus Drug‐Eluting Stents in Small Vessel De Novo Coronary Artery Disease: A Systematic Review and Meta‐Analysis”
by: Richard G. Bogle, et al.
Published: (2026)

Comparison of Oxidative Stress Effects Between Drug‐Eluting Stents and Drug‐Coated Balloons: Insights Into Vascular Response and Clinical Implications
by: Muzaffer Aslan, et al.
Published: (2025)

Drug Coated Balloon in Young Patients With ST‐Elevation Myocardial Infarction: A Viable Treatment Option?
by: Davor Vukadinović, et al.
Published: (2025)

Long‐Term Clinical Outcomes of Drug‐Coated Balloon Following Directional Coronary Atherectomy for Bifurcated or Ostial Lesions in the DCA/DCB Registry
by: Shunsuke Kitani, et al.
Published: (2024)

Drug‐Coated Balloon Treatment for LAD CTO in a Young Woman With Moyamoya Disease Guided by Intravascular Imaging
by: Shuangliang Ma, et al.
Published: (2024)

Real‐World Safety and Complications of the Boston Scientific AGENT Drug‐Coated Balloon From the FDA MAUDE Database
by: Sant Kumar, et al.
Published: (2025)

Drug‐Coated Balloons in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS‐CTO Registry
by: Deniz Mutlu, et al.
Published: (2025)

Drug‐Coated Balloons Versus Drug‐Eluting Stents for De Novo Ostial Left Circumflex Lesions: The International Multicenter DCB‐CIRCO Registry
by: Francesco Tartaglia, et al.
Published: (2025)

Predictors of recurrent restenosis after repeat drug‐coated balloon therapy for drug‐coated balloon restenosis in femoropopliteal lesions: Results of the RECURRENCE study
by: Takashi Yanagiuchi, et al.
Published: (2024)

Prognostic Value of Computational Pressure‐Flow Dynamics Derived FFR Measured Immediately After Successful Paclitaxel‑Coated Balloon Angioplasty for In‐Stent Restenosis Lesion
by: Wangwei Yang, et al.
Published: (2026)

Prognostic Significance of Bailout Stenting for Residual Stenosis or Dissection Following Drug‐Coated Balloon Angioplasty: A Sub‐Analysis of the EASTBOURNE Study
by: Filippo Luca Gurgoglione, et al.
Published: (2025)

Physiologic Assessment Using Angiography‐Derived Fractional Flow Reserve After Drug‐Coated Balloon Angioplasty in De Novo Coronary Lesions
by: Chun‐Chin Chang, et al.
Published: (2026)

Coronary Angiography‐Derived Murray Law‐Based Quantitative Flow Ratio (μQFR) After De Novo Drug‐Coated Balloon Angioplasty
by: Dorian Garin, et al.
Published: (2025)

Comparison of Sirolimus—Versus Paclitaxel‐Coated Balloons in Coronary Artery Disease: One‐Year Results of Two Real‐World Prospective Registries
by: Selina Vlieger, et al.
Published: (2025)